Skip to main content
. 2018 Nov 2;9(86):35639–35654. doi: 10.18632/oncotarget.26257

Table 2. ChIP primers used for the study.

Promoter region Forward primer Reverse primer
I.1 (-533) TCACCCCCAACACATAGCAC CCACCACACACCACATTGTTC
I.1 (-802) GAGGGAGGGTTGACACTCAG CCAGCTGCTCACAGGGTAAT
I.1 (-835) GAGGGAGGGTTGACACTCAG TGGTGGGTATTGCTGAGAGATG
I.1 (-1149) GGTAGAGCCTCTGAGAATGCAC CATCCCCTCCCAGTCATCAT
2a CAATCAGTGTGATGGCCCCT GTCAGAAGACACCCCACCAG
I.4 CACTCACCTGGCACCTAACC AAGAGCCACACACTGGGAAG
pII CGTCACTCTACCCACTCAAGG AGTCTCAGGTTCCTTTAGACGC